AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
Form_NN
20-F_NN
Information_NOMZ
2004_CD
97_CD
22_CD
Net_JJ
cash_NN
inflow_NN
from_PIN
trading_GER
operations_NOMZ
2004 2003 2002_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Operating_GER
profit_NN
before_IN
exceptional_JJ
items_NN
4,770_CD
4,111_CD
4,356_CD
Depreciation_NOMZ
,_,
amortisation_NOMZ
and_PHC
impairment_NOMZ
1,268_CD
1,290_CD
960_CD
Stocks_NN
decrease_VPRT
increase_NN
129 131 101_CD
Debtors_NN
increase_NN
209 540 198_CD
Creditors_NN
increase_NN
decrease_NN
71 430 402_CD
Other_JJ
non-cash_JJ
movements_NOMZ
including_VBG [WZPRES]
exchange_NN
40_CD
317_CD
65_CD
6,069_CD
4,617_CD
5,686_CD
23_CD
Cash_NN
outflow_NN
related_VBN [WZPAST]
to_PIN
exceptional_JJ
items_NN
2004 2003 2002_CD
Current_JJ
period_NN
cash_NN
flow_NN
related_VBN [WZPAST]
to_PIN
exceptional_JJ
items_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
Synergy_NN
and_PHC
integration_NOMZ
costs_NN
25_CD
68_CD
Zoladex_NN
OIG_NN
settlement_NOMZ
355_CD
Costs_NN
relating_VBG [WZPRES]
to_PIN
disposals_NN
and_PHC
demerger_NN
of_PIN
other_JJ
businesses_NOMZ
8_CD
11_CD
25_CD
Outflow_NN
related_VBN [WZPAST]
to_PIN
exceptional_JJ
items_NN
8_CD
391_CD
93_CD
Details_NN
of_PIN
the_DT
cash_NN
inflows_NN
in_PIN
connection_NOMZ
with_PIN
the_DT
profit_NN
on_PIN
the_DT
sale_NN
of_PIN
an_DT
interest_NN
in_PIN
a_DT
joint_JJ
venture_NN
are_VPRT [PASS]
set_VBN
out_PIN
in_PIN
Note_NN
24_CD
._.
24_CD
Disposal_NN
of_PIN
business_NOMZ
operations_NOMZ
2004 2003 2002_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD [PASS]
Fixed_VBN
assets_NN
2_CD
70_CD
Current_JJ
assets_NN
17_CD
34_CD
Creditors_NN
due_JJ
within_PIN
one_CD
year_NN
7_CD
17_CD
Book_NN
value_NN
of_PIN
net_JJ
assets_NN
disposed_VBD
12_CD
87_CD
Disposal_NN
costs_NN
72_CD
Profit_NN
on_PIN
disposals_NN
274_CD
Less_RB
:_:
Cash_NN
included_VBD
in_PIN
undertakings_GER
disposed_VBD
3_CD
7_CD
Cash_NN
consideration_NOMZ
355_CD
80_CD
The_DT
cash_NN
consideration_NOMZ
is_VPRT [BEMA]
in_PIN
relation_NOMZ
to_PIN
the_DT
sale_NN
of_PIN
the_DT
Groups_NN
share_NN
of_PIN
the_DT
joint_JJ
venture_NN
Advanta_NN
BV_NN
,_,
which_WDT [SERE]
was_VBD [PASS]
completed_VBN
on_PIN
1_CD
September_NN
2004_CD
$_$
284m_CD
and_CC
the_DT
disposal_NN
of_PIN
the_DT
Durascan_JJ
business_NOMZ
in_PIN
the_DT
first_JJ
half_NN
of_PIN
the_DT
year_NN
$_$
71m_CD
._.
The_DT
profit_NN
on_PIN
disposal_NN
is_VPRT [PASS]
stated_VBN [PUBV]
after_IN
transaction_NOMZ
costs_NN
and_PHC
warranty_NN
provisions_NN
._.
The_DT
sale_NN
consideration_NOMZ
received_VBN [WZPAST]
in_PIN
2003_CD
was_VBD [BEMA]
in_PIN
relation_NOMZ
to_PIN
the_DT
sale_NN
of_PIN
Marlow_NN
Foods_NN
Limited_NN
,_,
which_WDT [SERE]
was_VBD [PASS]
completed_VBN
on_PIN
23_CD
May_POMD
2003_CD
._.
